Cargando…
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
In spite of recent diagnostic and therapeutic advances, the prognosis of pancreatic ductal adenocarcinoma (PDAC) remains very poor. As most patients are not amenable to curative intent treatments, optimized palliative management is highly needed. One key question is to what extent promising results...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479347/ https://www.ncbi.nlm.nih.gov/pubmed/34631442 http://dx.doi.org/10.5306/wjco.v12.i9.787 |